Cyteir Therapeutics Inc. is on the Cruelty Free Investing use of animals list because they conduct pre-clinical studies of their drugs on animals to assess a product’s safety profile.
The company mentioned on its website that they use animals for product testing.
“Preclinical studies to date have demonstrated Cyteir’s lead RAD51 modulator to be potent, highly selective for AID-positive cells, effective against cancer cells in vitro and in vivo, and well tolerated in preclinical animal models.” Read the following article
Cyteir Therapeutics, Inc. is a clinical-stage biotechnology company. The Company is focused on developing and commercializing precision oncology medicines that inhibit deoxyribonucleic acid (DNA) damage repair and cause cancer cell death through a therapeutic strategy known as synthetic lethality. The Company’s pipeline includes CYT-0851 and CYT-1853.
Company Website: https://cyteir.com